Condition
Vocal Fold Palsy
Total Trials
6
Recruiting
0
Active
0
Completed
4
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
25%
1 of 4 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 3 (1)
Trial Status
Completed4
Unknown2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT04764604Not ApplicableCompleted
Evaluating the Feasibility of Acapella® Choice as a Dysphonia Treatment
NCT05747859CompletedPrimary
Voice Telerehabilitation
NCT04700566Phase 3UnknownPrimary
Allograft Adipose Injectable for Vocal Fold Paralysis
NCT04315415Not ApplicableCompletedPrimary
A Histological Study Evaluating Silk Voice and Crosslinked Hyaluronic Acid
NCT03882450Not ApplicableCompletedPrimary
Universal Screening for Vocal Fold Motion Impairment in Children Undergoing Congenital Cardiac Surgery
NCT01501526Unknown
Unusual Clinical Findings of Herpes Esophagitis
Showing all 6 trials